Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand.
J Neurosci Res. 2024 Oct;102(10):e25389. doi: 10.1002/jnr.25389.
This study aims to compare the efficacy of 5-alpha-reductase inhibitors (5ARIs) on anxiety and depression between long-term and short-term treatment followed by withdrawal in d-galactose (Dgal)-induced senescent male rats. Thirty-two, 8-week-old, male Wistar rats were divided into two groups: control rats and Dgal-treated rats (150 mg/kg/day; subcutaneously) for 18 weeks. At week 13, Dgal-treated rats were subdivided into three subgroups: (1) vehicle (DgV), (2) long-term treatment with 5ARIs, Finasteride 5 mg/kg/day, per oral for 6 weeks (DgF), (3) short-term treatment with 5ARIs, Finasteride 5 mg/kg/day, per oral for 2 weeks followed by a 4-week withdrawal period (DgW). Anxiety and depression were assessed using the elevated-plus maze (EPM) and splash test (ST). Blood was collected for biochemical analysis. After euthanasia, the brains were removed to examine brain inflammation, oxidative stress, neuroactive steroids, brain metabolites, and brain senescent markers. We found that DgV rats exhibited metabolic disturbance with a reduced preference index of the EPM, and grooming duration in ST. Increased brain neurotoxic metabolites, along with increased brain inflammation/oxidative stress, and reduced microglia complexity were observed in the DgV rats. Both therapeutic approaches improved metabolic parameters and preference index in the open arm of EPM in Dgal-treated rats, while grooming duration and microglia complexity were increased only in DgF rats. Our results indicate that Fin reduces depression-like and anxiety-like behaviors by reducing brain inflammation, oxidative stress, and brain senescent. In conclusion, long-term treatment with 5ARIs is more effective in alleviating depression than short-term treatment followed by withdrawal in Dgal-induced early senescent male rats.
这项研究旨在比较 5α-还原酶抑制剂(5ARIs)在长期和短期治疗后停药对 D-半乳糖(Dgal)诱导的衰老雄性大鼠焦虑和抑郁的疗效。32 只 8 周龄雄性 Wistar 大鼠分为两组:对照组和 Dgal 处理组(150mg/kg/天;皮下)18 周。在第 13 周,Dgal 处理组分为三组:(1)载体(DgV),(2)长期使用 5ARIs,非那雄胺 5mg/kg/天,口服 6 周(DgF),(3)短期使用 5ARIs,非那雄胺 5mg/kg/天,口服 2 周后停药 4 周(DgW)。焦虑和抑郁通过高架十字迷宫(EPM)和飞溅测试(ST)评估。采集血液进行生化分析。安乐死后取出大脑,检查大脑炎症、氧化应激、神经活性甾体、大脑代谢物和大脑衰老标志物。我们发现 DgV 大鼠表现出代谢紊乱,EPM 的偏好指数降低,ST 中的梳理时间减少。DgV 大鼠的大脑神经毒性代谢物增加,大脑炎症/氧化应激增加,小胶质细胞复杂性降低。两种治疗方法均改善了 Dgal 处理大鼠的代谢参数和 EPM 开臂的偏好指数,而梳理时间和小胶质细胞复杂性仅在 DgF 大鼠中增加。我们的结果表明,非那雄胺通过降低大脑炎症、氧化应激和大脑衰老来减少抑郁样和焦虑样行为。总之,长期使用 5ARIs 比短期治疗后停药更能缓解 Dgal 诱导的早期衰老雄性大鼠的抑郁。